
Depression: Five Million Americans May Benefit From Psychedelic Therapy
Breakthrough therapy designations have been granted to use the active ingredient in magic mushrooms to treat depression and a broader approval may be coming.
Breakthrough therapy designations have been granted to use the active ingredient in magic mushrooms to treat depression and a broader approval may be coming.
FDA has issued psychedelic guidance, but the industry is struggling as decriminalization efforts gain traction and approval looms.
Learn about the latest research on neuroplasticity and mental health, including how psychedelics are being investigated for mood disorders.
Part two of this series covers the following Oregon psilocybin business issues: banking, raising money and licensed business siting.
Oregon psilocybin businesses will be subject to residency requirements, financial interest rules, and a heavy tax burden.
A new study reveals that psilocybin-containing mushroom extract exhibits a more potent and enduring effect on synaptic plasticity compared to its synthetic counterpart.
A recent study published in the Journal of Psychopharmacology suggests that psilocybin, the active component in "magic mushrooms", can induce lasting neuroplastic changes in the brain, which are associated with improvements in symptoms of depression. The research, which found significant increases in a specific EEG measure of neuroplasticity two weeks after a single psilocybin treatment session, heralds a promising avenue for depression treatment, albeit requiring further studies with larger and more diverse sample groups. ...
Psilocybin could be a game-changer in helping people reconnect with their body.
Psychedelic-assisted therapy refers to therapeutic practices that involve the ingestion of a psychedelic drug. Since the early 1990s, a new generation of scientists has revived the research. Clinical trials have shown that ingesting a psychedelic in a carefully prescribed and monitored setting can induce an experience that is medically safe and that provokes profound, durable psychological and behavioral change.
We asked James Kuo, vice president of R&D at Silo Pharma, about his predictions for the field of psychedelic research in 2023.
Psychedelic drugs being tested as therapies for treatment-resistant depression activate receptors within brain cells that promote new brain cell connections.
Australia will soon allow psychedelics MDMA and psilocybin to be used medically. The U.S. may not be too far behind, some experts say.
According to a meta-analysis that was published in the Journal of Psychoactive Drugs, psychedelic-assisted therapy was found to be significantly more effective in treating anxiety and depression in pa
Psychedelics such as LSD, psilocybin and MDMA are gaining increasing attention in scientific and medical circles because of the potential they hold for treating anxiety disorders and emotional trauma. UC's Nese Devenot explains why psychedelics are seeing a research renaissance.
Lectures from the 2023 Psychedelic Summit explore the possibilities and limitations of psychedelics to treat anxiety, depression, PTSD and other disorders.
Thousands are in Denver this week to learn about the future of psychedelics like magic mushrooms and MDMA, and to talk business.
After years of regulatory hurdles and societal stigma, psychedelic-assisted treatment for behavioral health conditions is coming into the spotlight.
In several ways, psychedelic therapy continued to make strides toward legitimization in 2022, but certainly not in an all.
What psychedelics really feel like, and where they can take us.
Are you ready for the psychedelic revolution? In the next few years, the FDA is likely to approve these mind-bending drugs for treating depression and post-traumatic stress disorder. Some states have already decriminalized psilocybin, the active ingredient in "magic" mushrooms. But for all the headlines, many questions are swirling around this psychedelic renaissance. How do we make these drugs effective, safe and accessible to the people who need the most help? And how can they be used ethically, when much of the knowledge about plant medicines comes from Indigenous cultures? Psychedelics also raise profound questions about the nature of consciousness and mystical experience. People often describe their psychedelic experiences as "more real" than everyday life. Is this just an illusion, or do these experiences tap into some deeper reality? In "Luminous," TTBOOK executive producer Steve Paulson explores the philosophical and cultural implications of psychedelics through conversations with scientists, healers and religious scholars. You can listen to each episode on the radio or find the series plus bonus extended conversations on Apple Podcasts, Spotify, YouTube or wherever you get your podcasts.
The presenters at an Annual Meeting session cautioned that patients pursuing psychedelic-assisted psychotherapy will benefit from physicians offering more, not less, information about the myriad ou...
A new paper argues that excitement has veered into misinformation—and scientists should be the ones to set things straight.
Scientists have gleaned new insights into how psychedelics alter conscious experience via their action on brain activity.
As MDMA and psilocybin treatments become more mainstream, the therapy component has come under scrutiny. Here’s what’s common in many sessions — and what’s not.
Researchers have discovered the active compound from an edible mushroom that boosts nerve growth and enhances memory.
The drug and a key ingredient in magic mushrooms will be used nationally to treat PTSD and depression.